You searched for "laser"
Blind Football Fan ‘Scores’ Support
25 January 2024
|
ECLO, RNIB, sight loss, patient stories, AMD, Age-related macular degeneration (AMD)
A Ross County supporter has praised the club and leading sight loss charity, RNIB Scotland, for helping him to keep attending games.
Poppers retinopathy: What is it and how do we treat it?
2 June 2025
| Alexander Benson
|
EYE - Vitreo-Retinal
Poppers retinopathy is a relatively unknown phenomenon which afflicts users of poppers but should be considered as a differential in sudden-onset or sub-acute visual acuity loss – particularly in patients with a history of recreational drug use. Raising awareness of...
Orbis marks 100-millionth antibiotic dose in the fight against trachoma in Ethiopia
Orbis and partners mark historic 100-millionth dose of azithromycin antibiotics in the fight to eliminate blinding trachoma in Ethiopia by 2030. This milestone was achieved 20 years after Orbis began leading mass drug administrations.Moorfields earns UK’s first UKAS accreditation for ophthalmic and vision science (IQIPS)
The United Kingdom Accreditation Service (UKAS) has granted the first accreditation for Ophthalmic and Vision Science to Moorfields Eye Hospital. The award was made to the Electrophysiology Department at Moorfields under the Improving Quality In Physical Services (IQIPS) programme.Four pillars: Exploring eye exigencies
2 June 2025
| Jem Ann Bautista
|
EYE - General
This series explores the four pillars of advanced clinical practice and here, Jem Ann Bautista explores the pillar of clinical practice. As day case theatre practitioners in one of London’s biggest and busiest centres, our team is trained to cater...
Optegra launches new fellowship programme
Leading eye health care group, Optegra, is proud to announce the appointment of its first Fellow, Mr Fadi Alfaqawi, as it unveils its Cataract and Refractive Surgery Fellowship Programme.Preview: Oxford Ophthalmological Congress
18 June 2024
| Samuel Verdin
|
conferences, events, Oxford, OOC, registration, opportunities, education, meeting, England, UK
Between 1–3 July, we will be heading down to England for the 107th Oxford Ophthalmological Congress.
RNIB launches new campaign to dispel myths and encourage people to ‘See the person, not the sight loss’
3 October 2022
Leading sight loss charity RNIB (Royal National Institute of Blind People) and The&Partnership has today (3 October 2022) launched a new campaign ‘See the person, not the sight loss’, challenging outdated public attitudes and misperceptions of sight loss.
Dexmedetomidine vs remifentanil for reduction of postoperative agitation
Postoperative agitation is a common anaesthetic complication in children with a significant impact to care and outcomes. The authors studied preschool children to compare the effect of intravenous administration of dexmedetomidine and remifentanil on postoperative agitation following strabismus surgery under...New study uncovers key mechanism behind a common genetic cause of age-related visual loss
19 September 2024
|
Cornea / External Eye Disease
|
endothelial cells, age, vision loss, research, academic, new, genetics, genome, Fuchs Endothelial Corneal Dystrophy, FECD
A groundbreaking study has revealed important insights into the mechanisms behind Fuchs Endothelial Corneal Dystrophy (FECD), a common cause of age-related visual loss, providing hope for future therapeutic developments, and finding implications for other neurological diseases. FECD is a common,...
The founder of modern ophthalmology: Sir William Stewart Duke-Elder
A recent article in Eye News by Blaikie & King highlighted the extraordinary contribution made to the profession of ophthalmology by Sir William Stewart Duke-Elder. The author felt it appropriate to take a further in-depth look at the remarkable career...Age and gender impacts effectiveness of new gene therapy treatments for eye diseases, new study finds
14 February 2025
|
research, genetics, gene therapy, pathology, education, Adeno-Associated Virus, inflammation
Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found. The University of Bristol-led study, published in Molecular Therapy, reveal how age and gender affects inflammation caused by gene...
